Market optimism over the potential for interest rate cuts next year is dangerously overdone, according …
Read More »GlaxoSmithKline, 23andMe team up on genetics-driven drug research
Cayce Clifford | Bloomberg | Getty Images A reporter examines a 23andMe DNA genetic testing kit in Oakland, California. British drug giant GlaxoSmithKline is investing $300 million in consumer genetics company 23andMe, forging a four-year collaboration to discover medicines using human genetics as a guide. The partnership establishes GSK as …
Read More »